Screener
CURE vs SPXL
Direxion Daily Healthcare Bull 3X Shares vs Direxion Daily S&P500 Bull 3X Shares
Key differences
- SPXL costs 0.10% less per year.
- SPXL is significantly larger than CURE — larger funds tend to be more liquid and less likely to close.
- Over the last 3 years, SPXL has delivered higher annualized returns.
Side-by-side comparison
| CURE | SPXL | |
|---|---|---|
| Annual cost (TER) | 0.94% | 0.84% |
| Fund size (AUM) | $138M | $5.9B |
| Since | 2011 | 2008 |
| Dividend yield | 1.33% | 0.60% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | leveraged | leveraged |
| CAGR 1Y | +31.7% | +87.0% |
| CAGR 3Y | +0.8% | +55.4% |
| CAGR 5Y | +0.7% | +23.9% |
| Sharpe 3Y | 0.14 | 1.14 |
| Volatility 1Y | 42.92% | 35.92% |
| Max drawdown | -69.19% | -76.86% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to CURE and SPXL
Explore further